Author:
Zeng Qing-Lei,Chen Ru-Yue,Lv Xue-Yan,Huang Shuo,Li Wei-Zhe,Pan Ya-Jie,Wang Fu-Sheng,Yu Zu-Jiang
Funder
National Natural Science Foundation of China
Henan Provincial Science Fund for Distinguished Young Scholars, China
Health Science and Technology Innovation Fund for Distinguished Young Scholars, Health Commission of Henan Province, China
Program for Science & Technology Innovation Talents in Universities of Henan Province, China
Funding for Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University, China
Young and Middle-aged Academic Leaders of Health Commission of Henan Province, China
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Polaris Observatory Collaborators. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet Gastroenterol Hepatol. 2023;8(10):879–907.
2. Zeng QL, Yu ZJ, Ji F, Li GM, Zhang GF, Xu JH, et al. Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective. Observational Study Clin Infect Dis. 2021;73(9):e3324–32.
3. Zeng QL, Zhang HX, Zhang JY, Huang S, Li WZ, Li GM, et al. Tenofovir Alafenamide for Pregnant Chinese Women With Active Chronic Hepatitis B: A Multicenter Prospective Study. Clin Gastroenterol Hepatol. 2022;20(12):2826–37 e2829.
4. Li M, Li Q, Qu J, Yang H, Lv T, Kong Y, Zhang H. The effectiveness of combination therapy with interferon and nucleoside analogs in pediatric patients with chronic hepatitis B: a systematic review and meta-analysis. Hepatol Int. 2023;17(1):52–62.
5. Ling SC, Lin HS, Murray KF, Rosenthal P, Mogul D, Rodriguez-Baez N, et al. Chronic Hepatitis Is Common and Often Untreated Among Children with Hepatitis B Infection in the United States and Canada. J Pediatr. 2021;237:24-33 e12.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献